Morgan Stanley
TLSA icon

Morgan Stanley’s Tiziana Life Sciences TLSA Stock Holding History

Morgan Stanley’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$61K Hold
52,156
– – ﹤0.01% 6344
2025
Q4 		$77.7K Sell
52,156
-44,946
-46% -$80.7K ﹤0.01% 6286
2025
Q3 		$210K Buy
97,102
+23,831
+33% +$44.1K ﹤0.01% 5867
2025
Q2 		$116K Sell
73,271
-65,761
-47% -$87.9K ﹤0.01% 6076
2025
Q1 		$150K Buy
139,032
+28,201
+25% +$27.6K ﹤0.01% 5847
2024
Q4 		$77.2K Buy
110,831
+1,084
+1% +$1K ﹤0.01% 6149
2024
Q3 		$105K Sell
109,747
-769
-0.7% -$777 ﹤0.01% 5985
2024
Q2 		$102K Sell
110,516
-15,622
-12% -$11.4K ﹤0.01% 5959
2024
Q1 		$57.3K Sell
126,138
-122,124
-49% -$64K ﹤0.01% 6161
2023
Q4 		$139K Buy
248,262
+120,628
+95% +$76.1K ﹤0.01% 6063
2023
Q3 		$84.2K Sell
127,634
-2,297
-2% -$1.58K ﹤0.01% 5965
2023
Q2 		$88.5K Buy
129,931
+11,806
+10% +$9.99K ﹤0.01% 6006
2023
Q1 		$129K Sell
118,125
-25,434
-18% -$16.6K ﹤0.01% 5909
2022
Q4 		$85.9K Sell
143,559
-38,441
-21% -$25.5K ﹤0.01% 6053
2022
Q3 		$142K Buy
182,000
+31,083
+21% +$23.4K ﹤0.01% 5899
2022
Q2 		$112K Buy
150,917
+56,057
+59% +$48.2K ﹤0.01% 6214
2022
Q1 		$100K Sell
94,860
-19,848
-17% -$17.6K ﹤0.01% 6312
2021
Q4 		$110K Sell
114,708
-64,753
-36% -$85.8K ﹤0.01% 6386
2021
Q3 		$262K Sell
179,461
-102,156
-36% -$189K ﹤0.01% 5861
2021
Q2 		$660K Sell
281,617
-16,246
-5% -$40.2K ﹤0.01% 5345
2021
Q1 		$825K Sell
297,863
-13,058
-4% -$43.3K ﹤0.01% 4842
2020
Q4 		$628K Sell
310,921
-39,084
-11% -$124K ﹤0.01% 4935
2020
Q3 		$1.17M Buy
350,005
+318,775
+1,021% +$1.24M ﹤0.01% 4097
2020
Q2 		$80K Buy
+31,230
New +$57.3K ﹤0.01% 5503

Other funds holding TLSA

DIG
Dauntless Investment Group Etna, New Hampshire $151M AUM 76.14% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $2.89B AUM 18.44% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $89.9B AUM 20.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Morgan Stanley's TLSA Position: Q1 2026 in Review

Morgan Stanley held its Tiziana Life Sciences (TLSA) position steady in Q1 2026 at 52,156 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #6344.

Morgan Stanley first reported a position in TLSA in Q2 2020 and has held it in 24 quarters since. The position peaked at $1.17M in Q3 2020. 32 funds tracked by Wall St. Rank hold TLSA as of Q1 2026.

  • Morgan Stanley held 52,156 shares of Tiziana Life Sciences worth $61K as of Q1 2026.
  • Morgan Stanley left its Tiziana Life Sciences share count unchanged in Q1 2026.
  • Tiziana Life Sciences made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #6344 holding.
  • Morgan Stanley first reported a position in Tiziana Life Sciences in Q2 2020 and has held it in 24 quarters since.
  • Morgan Stanley's Tiziana Life Sciences position peaked at $1.17M in Q3 2020.
  • 32 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.